Literature DB >> 17187487

Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies.

Michael M Ling1, Claude Ricks, Peter Lea.   

Abstract

Enzyme-linked immunosorbent assays (ELISA) are frequently used for quantitative measurement of the presence of protein, for single-analyte testing, in a sample. The application of ELISA in a microarray format has the potential to simultaneously measure the presence and/or concentrations of numerous proteins, in multiplex testing, all contained in a small drop of test fluid. Microspot microarray technology, in combination with protein biomarkers and nucleic acid diagnostics, appears to be the future high-performance analytical platform of choice. Validation of a large number of disease markers in both molecular and protein diagnostics has paved the way for the emergence of the multiplex assay. Initially, simple low-throughput multiplex assays were tested using the immunoassay format. These were followed by low-level multiplexing and high-throughput array-based immunoassays. More recently, two types of high-level multiplexing and high-throughput diagnostic methods using microspot arrays and bead arrays have been successfully developed to complement single-analyte assays. The value in rapid diagnostic evaluation for high-throughput multiplex, diagnostic test systems based on sound assay design must take into account data screening, normalization and statistical evaluation of possible concentration measurement, data errors and automated operation. Benefits of using multiplex array platforms include improved-quality patient care, as well as cost effectiveness and time saving. These multiplex methods also set the stage for future protein/nucleic acid codetection. Currently, the one analyte at a time test scheme is still dominant; nonetheless, the multiplex microspot microarray tests evaluated in a single multiassay analyzer are expected to become a significant part of clinical diagnostic testing within the next 5-10 years. This review is focused on microspot array and bead array methods for providing high throughput and a high degree of multiplexing in diagnostic testing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17187487     DOI: 10.1586/14737159.7.1.87

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  24 in total

Review 1.  Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

Authors:  Darshana Jani; John Allinson; Flora Berisha; Kyra J Cowan; Viswanath Devanarayan; Carol Gleason; Andreas Jeromin; Steve Keller; Masood U Khan; Bill Nowatzke; Paul Rhyne; Laurie Stephen
Journal:  AAPS J       Date:  2015-09-16       Impact factor: 4.009

Review 2.  Diagnosis of hepatitis via nanomaterial-based electrochemical, optical or piezoelectrical biosensors: a review on recent advancements.

Authors:  Soodabeh Hassanpour; Behzad Baradaran; Miguel de la Guardia; Amir Baghbanzadeh; Jafar Mosafer; Maryam Hejazi; Ahad Mokhtarzadeh; Mohammad Hasanzadeh
Journal:  Mikrochim Acta       Date:  2018-12-01       Impact factor: 5.833

Review 3.  Suspension arrays based on nanoparticle-encoded microspheres for high-throughput multiplexed detection.

Authors:  Yuankui Leng; Kang Sun; Xiaoyuan Chen; Wanwan Li
Journal:  Chem Soc Rev       Date:  2015-05-29       Impact factor: 54.564

Review 4.  Early identification of cardiovascular risk using genomics and proteomics.

Authors:  Iftikhar J Kullo; Leslie T Cooper
Journal:  Nat Rev Cardiol       Date:  2010-05-04       Impact factor: 32.419

Review 5.  Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.

Authors:  Qi Liu; Xiang Wang; Tian Xia
Journal:  Anal Bioanal Chem       Date:  2018-08-01       Impact factor: 4.142

6.  Comparison of multiplex immunoassay platforms.

Authors:  Qin Fu; Jie Zhu; Jennifer E Van Eyk
Journal:  Clin Chem       Date:  2009-12-18       Impact factor: 8.327

Review 7.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

Review 8.  Early diagnosis of disease using microbead array technology: A review.

Authors:  Sanam Foroutan Parsa; Atieh Vafajoo; Azin Rostami; Reza Salarian; Mohammad Rabiee; Navid Rabiee; Ghazal Rabiee; Mohammadreza Tahriri; Amir Yadegari; Daryoosh Vashaee; Lobat Tayebi; Michael R Hamblin
Journal:  Anal Chim Acta       Date:  2018-05-04       Impact factor: 6.558

Review 9.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

Authors:  K Brookes; J Cummings; A Backen; A Greystoke; T Ward; G C Jayson; C Dive
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.